课题基金 / 基金详情

EFFECT OF VON WILLEBRAND FACTOR ON THE ACTIVITY OF FACTOR VIII

EFFECT OF VON WILLEBRAND FACTOR ON THE ACTIVITY OF FACTOR VIII
血管性血友病因子对因子 VIII 活性的影响
批准号:
3811121
负责人:
WILLIAM FRICKE
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

WILLIAM FRICKE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Investigation of interaction between factor VIII (fVIII) and von Willebrand factor (vWF) has been undertaken along several lines. First, the ability of vWF to block the interaction of factor VIII with antibodies to factor VIII has been studied by using the Bethesda assay. Inhibition of factor VIII activity by the antibodies is greatest when factor VIII preparations containing little or no vWF are tested (approx. 12,000 BU), decreases to about 5,000 BU for ratios of fVIII:vWF seen in plasma, and to 3500 for preparations with 3 times more vWF than fVIII. Ongoing work is intended to determine if this vWF effect is due to a vWF effect on the assay or represents blocking of the antibody by vWF. Second, the effect of vWF on factor VIII assays is being studied. Data generated thus far indicate that the vWF:Ag level must be at least 50% or normal for full expression of FVIII:C. And, third, the association of FVIII:Ag with individual vWF multimers is being investigated by SDS-agarose electrophoresis using radiolabelled anti-FVIII antibodies. Preliminary data indicate that FVIII is found in association with the small and intermediate size multimers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EFFECT OF VON WILLEBRAND FACTOR ON THE ACTIVITY OF RECOMBINANT FACTOR VIII
STANDARDIZATION OF COAGULATION FACTOR IX
EFFECT OF TRANSEXAMIC ACID ON BLEEDING IN THROMBOCYTOPENIC PATIENTS
SEROCONVERSION SURVEILLANCE PROJECT
海外基金